Zimbabwe has declined a substantial US healthcare agreement worth $367m (272 million pounds) over five years because of Washington's demand for confidential data.
This move was revealed after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesperson later stated that the US was demanding access to biological samples for research and profit but was not willing to guarantee the benefits from future medical innovations.
"We must now begin the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for more talks to find a agreement acceptable to both sides so the nation's critical HIV programme can proceed.
Broader Background
This development comes after a comparable case in neighbouring Kenya, where a court suspended a similar deal with the US following legal challenges were raised about the security of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump claimed its spending was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and responsibility.
Based on statements, 16 African countries have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any corresponding guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Put simply, our country would provide the basic resources for medical research without any assurance that the resulting innovations would be available to our people should a new health crisis arise."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting frameworks already set up via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to deal with future global health emergencies.
"This framework is designed to guarantee that when a country contributes its data, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We are open to continued discussions with our US partners on how future collaboration might be arranged in a way that respects the independence and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that negotiations need to persist since much of the country's HIV programmes relied on external financing.
"In cases where specific concerns arise, such as those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group commented.
The situation emphasises the continuing tensions between accepting vital foreign assistance and protecting national sovereignty in an ever more data-driven world.